News

Filter

Current filters:

None

Popular Filters

7950 to 7974 of 8448 results

Novel approach for multiple sclerosis treatment identified by Biogen Idec

04-07-2011

US biotech firm Biogen Idec (Nasdaq: BIIB) has revealed results from a study that suggest that inhibiting…

Biogen IdecBiotechnologyNeurologicalPharmaceuticalResearch

Government of Zambia provides incentives for pharma industry

04-07-2011

The Zambian government last week introduced incentives aimed at protecting the local steel-iron and pharmaceutical…

GenericsRegulationRest of the World

Novartis gets US and Japanese approval for COPD drug Arcapta/Onbrez

04-07-2011

In two pieces of good news for Swiss drug major Novartis (NOVN: VX) on Friday, the company announced…

ArcaptaAsia-PacificNorth AmericaNovartisOnbrezPharmaceuticalRegulationRespiratory and Pulmonary

EU Commission's research funding plans slammed by scientists and NGOs

04-07-2011

In an open letter sent last week to the President and Members of the European Commission, as well as…

EuropeFinancialPharmaceuticalResearch

Boost for Dendreon, as CMS to cover Provenge treatment and FDA OKs production facility

04-07-2011

There was a batch of good news for Seattle, USA-based Dendreon (Nasdaq: DNDN) that support broad availability…

BiotechnologyDendreonNorth AmericaOncologyPharmaceuticalPricingProvengeRegulation

UK NICE says benefits of breast cancer drugs Tyverb and Herceptin still unproven

03-07-2011

In a draft guidance issued last Friday, the UK’s drug watchdog, the National Institute for Health…

GlaxoSmithKlineHerceptinOncologyPharmaceuticalPricingRegulationRocheTyverb

Australian government report on inappropriate use of intellectual property rights in medicines

03-07-2011

The Australian government last week tabled its report to Parliament on barriers to medicines entering…

Asia-PacificGenericsPatentsPoliticsRegulation

Novartis COPD drug candidate NVA237 superior to placebo and similar to tiotropium in Ph III

01-07-2011

Swiss drug major Novartis (NOVN: VX) has announced positive results from the pivotal Phase III GLOW2…

NovartisPharmaceuticalResearchRespiratory and PulmonarySoseiVectura

US NDA filings for Vivus’ ED drug avanafil and Corcept’s Corlux for Cushing’s

01-07-2011

California, USA-based Vivus (Nasdaq: VVUS) has submitted a New Drug Application has to the Food and Drug…

avanafilCorluxNorth AmericaPharmaceuticalRare diseasesRegulationReproductiveVivus

Pfizer and ChemRar plan to explore innovative R&D partnership in Russia

01-07-2011

Following in the footsteps of Switzerland’s Roche, global drugs behemoth Pfizer (NYSE: PFE) has…

Cardio-vascularChemRar Hi-TechOncologyPfizerPharmaceuticalResearch

Doctors tell US FDA: “HIV prevention pill” - Gilead's Truvada - not ready for approval

01-07-2011

Last week, a group of 55 US physicians sent a letter to the Food and Drug Administration urging the agency…

Anti-viralsGilead SciencesNorth AmericaPharmaceuticalRegulationTruvada

Novartis’ Gilenya has begun to impact established DMAs and market perceptions; report

01-07-2011

While physician trialing of Swiss drug major Novartis’ (NOVN: VX) Gilenya (fingolimod), the first…

GilenyaMarkets & MarketingNeurologicalNovartisPharmaceutical

Pennsylvania Bio collaborates with Italian biotech association

30-06-2011

The USA’s Pennsylvania Bio, the only state-wide trade association representing Pennsylvania’s…

BiotechnologyEuropeNorth AmericaResearch

Canada falling back on innovation performance, says STIC

30-06-2011

Canada’s innovation performance has slumped on most key measures over the past two years, according…

North AmericaPatentsPharmaceuticalResearch

Bayer and Regeneron file for Japanese approval of wet AMD drug Eylea

30-06-2011

Following swiftly on receiving a strong backing for the product from a US Food and Drug Administration…

Asia-PacificBayerEyleaOphthalmicsPharmaceuticalRegeneronRegulationVEGF Trap-Eye

7950 to 7974 of 8448 results

Back to top